HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.

4th Edition of Global Conference on Gynecology & Women's Health

September 28-30, 2026 | London, UK

High Throughput Sequencing In Gynaecology

High Throughput Sequencing In Gynaecology

High throughput sequencing (HTS) is a powerful molecular tool for analyzing the genomic data of gynecological samples. HTS enables researchers to identify genetic alterations associated with gynecological diseases, as well as to detect the presence of infectious agents in gynecological samples. HTS can also be used to study the transcriptome and epigenetic profile of gynecological samples, providing valuable insights into the mechanisms underlying gynecological diseases. HTS has been widely used in the study of gynecological cancers, such as ovarian, cervical, and endometrial cancer. Using HTS, researchers can identify the genetic alterations associated with these types of cancer and develop targeted therapies to treat them. HTS is also useful for identifying novel biomarkers to diagnose and monitor gynecological cancers. In addition to its use in cancer research, HTS can also be used to study non-malignant gynecological diseases such as endometriosis and polycystic ovary syndrome. HTS can help identify genetic variants associated with these diseases and provide insights into their underlying mechanisms. Furthermore, HTS can be used to detect the presence of infectious agents such as HPV, which can cause cervical cancer. Overall, HTS is a powerful tool for studying gynecological diseases. HTS has enabled researchers to gain valuable insights into the causes and development of these diseases, as well as to develop targeted therapies for treating them. As HTS technologies continue to advance, it is likely that HTS will become an increasingly important tool for gynecological research.

Submit your abstract Today

Watsapp